These side effects deplete fluids and electrolytes
Everywhere I look, people are finally losing weight, yet just as many are stuck waiting for a clinic to call myBMI Weight Loss Review: UK-Regulated GLP-1 Care Losing weight shouldnt feel like banging my head against a wall, but thats how its been
The covariates were adjusted in the PSM model for a priori-identified potential confounders, such as age, sex, race/ethnicity, nicotine dependence, BMI, type 2 diabetes, hypertension, hyperlipidaemia, hypercholesterolaemia, chronic respiratory disease, chronic renal diseases, BP, chronic kidney disease, peripheral vascular diseases, diabetes-related microvascular complications, glomerular diseases, cirrhosis of the liver, osteoporosis, sleep apnoea, abnormal laboratory findings (HbA 1c , serum cholesterol, LDL-cholesterol, HDL-cholesterol and triacylglycerol [TG]) and intake of cardiovascular medications (Table 1)
Zweifel, Richard (1992)
Rivera FB, Cruz LLA, Magalong JV et al (2024) Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials